News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Beech Tree Labs, Inc.’ Data Points Toward Potential TB Treatment
September 13, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PROVIDENCE, R.I.--(BUSINESS WIRE)--Beech Tree Labs, Inc. announced today publication of data providing evidence that its novel product candidate addressing scarring and wound healing showed efficacy in a Mycobacterium tuberculosis (TB) animal model.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
MORE ON THIS TOPIC
IN PARTNERSHIP WITH IQVIA
How Target Product Profiles Guide the Industry Through Uncertain Times
May 22, 2025
·
1 min read
·
Lori Ellis
Opinion
Evolving Market Pressures Force Biopharma Companies to Cut Assets Early
May 21, 2025
·
5 min read
·
Michael N. Abrams
Rare diseases
CRISPR Success in Single Baby Highlights Rare Disease ‘Crisis’
May 20, 2025
·
3 min read
·
Dan Samorodnitsky
Cardiovascular disease
Ionis Builds Triglyceride-Lowering Case for RNA-Targeting Tryngolza
May 20, 2025
·
2 min read
·
Tristan Manalac